EXT2 and central nervous system cancer: By contrast, EXT2 preferentially interacted with glypicans and syndecans, reinforcing its involvement in cell adhesion and cytoskeletal remodeling, consistent with its enrichment in mesenchymal-like glioma cells and Ras homology (Rho) guanosine triphosphatase (GTPase)-driven invasive programs.